<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7192973\results\search\drugs\results.xml">
  <result pre="threat [[2], [3], [4]]. Vaccination and antiviral drugs such as" exact="oseltamivir" post="are efficient approaches for controlling influenza symptoms, but numerous"/>
  <result pre="overnight at 37 °C with 5% CO2, cells were treated with" exact="dimethyl sulfoxide" post="(DMSO) or two-fold serial dilutions of erucic acid (9.375 nM"/>
  <result pre="with diluted compounds including erucic acid and the positive control" exact="oseltamivir" post="carboxylate (TLC PharmaChem., Inc., Canada) in TPCK-trypsin (1.5 μg/mL) containing"/>
  <result pre="for 7 days) at 2 days prior to viral infection;" exact="oseltamivir" post="phosphate treatment group, intragastric administration of oseltamivir phosphate (60 mg/kg/d,"/>
  <result pre="to viral infection; oseltamivir phosphate treatment group, intragastric administration of" exact="oseltamivir" post="phosphate (60 mg/kg/d, for 7 days) at 2 days prior"/>
  <result pre="For viral infection, mice were anesthetized by inhalation of 5%" exact="isoflurane" post="and inoculated intranasally with 5 LD50 of mouse-adapted A/FM/1/47(H1N1)"/>
  <result pre="drugs are used clinically in influenza therapy; however, even early" exact="oseltamivir" post="treatment does not improve the outcome of critically ill"/>
  <result pre="inflammatory and wnt-mediated signaling in miceJ. Virol.9020152240225326656717 7KumarA.Early versus late" exact="oseltamivir" post="treatment in severely ill patients with 2009 pandemic influenza"/>
 </snippets>
</snippetsTree>
